Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ronald T. Gansevoort"'
Autor:
Ronald D. Perrone, Ali Hariri, Pascal Minini, Curie Ahn, Arlene B. Chapman, Shigeo Horie, Bertrand Knebelmann, Michal Mrug, Albert C.M. Ong, York P.C. Pei, Vicente E. Torres, Vijay Modur, Ronald T. Gansevoort
Publikováno v:
Kidney Medicine, Vol 4, Iss 10, Pp 100538- (2022)
Rationale & Objective: Venglustat, a glucosylceramide synthase inhibitor, inhibits cyst growth and reduces kidney failure in mouse models of autosomal dominant polycystic kidney disease (ADPKD). STAGED-PKD aims to determine the safety and efficacy of
Externí odkaz:
https://doaj.org/article/66ff3b0e6417477da59ccf6a9cdbba1d
Autor:
Ronald T, Gansevoort, Ali, Hariri, Pascal, Minini, Curie, Ahn, Arlene B, Chapman, Shigeo, Horie, Bertrand, Knebelmann, Michal, Mrug, Albert Cm, Ong, York Pc, Pei, Vicente E, Torres, Vijay, Modur, Igor, Antonshchuk, Ronald D, Perrone
Publikováno v:
American Journal of Kidney Diseases, 81(5), 517-527.e1. W B SAUNDERS CO-ELSEVIER INC
Rationale & Objective: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the formation of multiple kidney cysts that leads to growth in total kidney volume (TKV) and progression to kidney failure. Venglustat is a glucosylcerami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::124719c907294fe39ba73b86da5cc421
https://research.rug.nl/en/publications/2524f3fb-67b7-4b6a-84d7-08d0fa5f43ad
https://research.rug.nl/en/publications/2524f3fb-67b7-4b6a-84d7-08d0fa5f43ad
Autor:
AMY A. Sarma, SAMANTHA M. PANIAGUA, EMILY S. LAU, DONGYU WANG, ELIZABETH E. LIU, MARTIN G. LARSON, NAOMI M. HAMBURG, GARY F. MITCHELL, JORGE KIZER, BRUCE M. PSATY, NORRINA B. ALLEN, A. TITIA LELY, RONALD T. GANSEVOORT, EMILY ROSENBERG, KENNETH MUKAMAL, EMELIA J. BENJAMIN, RAMACHANDRAN S. VASAN, SUSAN CHENG, DANIEL LEVY, RUDOLF A. DE BOER, JOHN S. GOTTDIENER, SANJIV J. SHAH, JENNIFER E. HO
Publikováno v:
JOURNAL OF CARDIAC FAILURE. Churchill Livingstone
Objective: Greater parity has been associated with cardiovascular disease risk. We sought to find whether the effects on cardiac remodeling and heart failure risk are clear.Methods: We examined the association of number of live births with echocardio
Autor:
James P. Corsetti, Stephan J. L. Bakker, Ronald T. Gansevoort, Eke G. Gruppen, Margery A. Connelly, Charles E. Sparks, Robin P. F. Dullaart
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 4, p 977 (2019)
Lipoproteins containing apolipoprotein B modify associations of elevated urinary albumin excretion (UAE) with cardiovascular disease (CVD). Additionally, it is known that elevated UAE alters high-density lipoprotein functionality. Accordingly, we exa
Externí odkaz:
https://doaj.org/article/e32b13ab625c4c0092dc5987f3d2f03a
Autor:
Setor K Kunutsor, Stephan J L Bakker, Jenny E Kootstra-Ros, Ronald T Gansevoort, John Gregson, Robin P F Dullaart
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0132822 (2015)
Alkaline phosphatase (ALP) has been suggested to be associated with cardiovascular disease (CVD) risk, however, important aspects of the association, such as shape and independence from established risk factors, have yet to be characterized in detail
Externí odkaz:
https://doaj.org/article/172e128d7af746da86dedc30da111760
Autor:
Katarina Mirković, Carolina R C Doorenbos, Wendy A Dam, Hiddo J Lambers Heerspink, Maartje C J Slagman, Ferdau L Nauta, Andrea B Kramer, Ronald T Gansevoort, Jacob van den Born, Gerjan Navis, Martin H de Borst
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e55887 (2013)
Non-invasive tubulointerstitial damage markers may allow better titration and monitoring of renoprotective therapy. We investigated the value of urinary vitamin D binding protein excretion (uVDBP) as a tubulointerstitial inflammation and fibrosis mar
Externí odkaz:
https://doaj.org/article/68c6f354370246a4b0432d0b83941842
Autor:
Nynke Halbesma, Auke H. Brantsma, Stephan J.L. Bakker, Desiree F. Jansen, Ronald P. Stolk, Dick De Zeeuw, Paul E. De Jong, Ronald T. Gansevoort, null for the PREVEND study group
Publikováno v:
Kidney International, 74(4), 505-512. ELSEVIER SCIENCE INC
We sought to identify predictors of the decline in renal function, especially those that are modifiable, in the 5488 participants of the prospective, community-based cohort study PREVEND who completed three visits during a mean follow-up of 6.5 years
Publikováno v:
Journal of nephrology. 21(2)
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common hereditary disorders. It accounts for 6% of the incidence of end-stage renal disease in Europe. Over the last decade, knowledge of the pathology underlying this disease ha
Autor:
Ronald T. Gansevoort, Jacoline Brinkman, Stephan J. L. Bakker, Paul E. De Jong, Dick de Zeeuw
Publikováno v:
American Journal of Epidemiology; Oct2006, Vol. 164 Issue 8, p725-727, 3p
Autor:
Ronald T. Gansevoort, Jacoline Brinkman, Stephan J. L. Bakker, Paul E. De Jong, Dick de Zeeuw
Publikováno v:
American Journal of Epidemiology; Oct2006, Vol. 164 Issue 8, p731-732, 2p